Innometry (Korea) Performance
| 302430 Stock | KRW 8,110 60.00 0.75% |
The company retains a Market Volatility (i.e., Beta) of -0.14, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Innometry are expected to decrease at a much lower rate. During the bear market, Innometry is likely to outperform the market. At this point, Innometry has a negative expected return of -0.34%. Please make sure to check out Innometry's standard deviation, total risk alpha, maximum drawdown, as well as the relationship between the jensen alpha and treynor ratio , to decide if Innometry performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Innometry Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
| Total Cashflows From Investing Activities | -9.6 B |
Innometry |
Innometry Relative Risk vs. Return Landscape
If you would invest 1,011,000 in Innometry Co on August 28, 2024 and sell it today you would lose (200,000) from holding Innometry Co or give up 19.78% of portfolio value over 90 days. Innometry Co is generating negative expected returns and assumes 2.7253% volatility on return distribution over the 90 days horizon. Simply put, 24% of stocks are less volatile than Innometry, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Innometry Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Innometry's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Innometry Co, and traders can use it to determine the average amount a Innometry's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1257
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 302430 |
Estimated Market Risk
| 2.73 actual daily | 24 76% of assets are more volatile |
Expected Return
| -0.34 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.13 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Innometry is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Innometry by adding Innometry to a well-diversified portfolio.
Innometry Fundamentals Growth
Innometry Stock prices reflect investors' perceptions of the future prospects and financial health of Innometry, and Innometry fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Innometry Stock performance.
| Return On Equity | 3.0 | |||
| Return On Asset | -0.0475 | |||
| Profit Margin | (0.16) % | |||
| Operating Margin | (0.19) % | |||
| Current Valuation | 138.2 B | |||
| Shares Outstanding | 4.83 M | |||
| Price To Sales | 2.67 X | |||
| Revenue | 46.47 B | |||
| EBITDA | (3.89 B) | |||
| Cash And Equivalents | 4.97 B | |||
| Total Debt | 222.19 M | |||
| Debt To Equity | 0.01 % | |||
| Cash Flow From Operations | (4.29 B) | |||
| Total Asset | 67.59 B | |||
About Innometry Performance
By analyzing Innometry's fundamental ratios, stakeholders can gain valuable insights into Innometry's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Innometry has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Innometry has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Innometry Co., Ltd. manufactures and sells X-ray inspection systems in South Korea. The company was founded in 2008 and is headquartered in Hwaseong, South Korea. INNOMETRY is traded on Korean Securities Dealers Automated Quotations in South Korea.Things to note about Innometry performance evaluation
Checking the ongoing alerts about Innometry for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Innometry help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Innometry generated a negative expected return over the last 90 days | |
| Innometry Co has accumulated about 4.97 B in cash with (4.29 B) of positive cash flow from operations. | |
| Roughly 54.0% of the company shares are owned by insiders or employees |
- Analyzing Innometry's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Innometry's stock is overvalued or undervalued compared to its peers.
- Examining Innometry's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Innometry's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Innometry's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Innometry's stock. These opinions can provide insight into Innometry's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Innometry Stock analysis
When running Innometry's price analysis, check to measure Innometry's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innometry is operating at the current time. Most of Innometry's value examination focuses on studying past and present price action to predict the probability of Innometry's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innometry's price. Additionally, you may evaluate how the addition of Innometry to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Stocks Directory Find actively traded stocks across global markets | |
| Transaction History View history of all your transactions and understand their impact on performance |